Cell Therapy and Bone Marrow Transplant Program

Our Program provides highly specialized, multidisciplinary care to patients from all 50 states and more than 55 countries. Ranked #1 in Texas, we perform more than 140 bone marrow and cell therapy transplants annually, including autologous and allogeneic procedures for malignant and non‑malignant conditions. Care is delivered in our 25‑bed inpatient transplant unit, the largest of its kind in the Southwestern U.S.  

What Sets Us Apart

Since 1997, our Program has delivered exceptional care to children, young adults, and their families within the Texas Medical Center, the largest medical complex in the world. Our multicultural team reflects the communities we serve, while bringing deep subspecialty expertise and a commitment to supporting patients from diagnosis through long-term follow-up. 

Key features that set our Program apart are:  

• A truly multidisciplinary team that provides comprehensive care that evolves with each patient’s needs
• Seven specialized clinics focused on the following areas: Graft‑Versus‑Host Disease (GVHD)│Hemoglobinopathies│Immune Disorders│Infectious Disease│BMT Long-Term Survivorship│Neurometabolic Disorders│Renal Complications
• Access to most commercially available gene therapies for sickle cell disease, thalassemia, and metabolic disorders
• End-to-end gene and cell therapy capabilities with in-house manufacturing, and innovative therapy development with Baylor College of Medicine’s Center for Cell and Gene Therapy
• Leadership in clinical research advancing cord blood and T cell therapies for resistant cancers